News

Gladstone in the News September 16, 2024

Guest Opinion: How Should We Pay for New Breakthrough Cures?

San Francisco Business Times—The world’s first CRISPR-based drug that alters the genetic code is on the market. Thousands of other therapies using gene editing or stem cell technologies are in the works and offer potential cures. But how will society pay for these life-saving drugs? In this opinion piece, Gladstone President Deepak Srivastava shares his views on a new world of medical possibilities.

Gladstone Experts Srivastava Lab

Article September 16, 2024

Meet Gladstone: Misha Zilberter

Misha Zilberter discusses his Alzheimer's disease research, the importance of collaboration in science, and the advice he has for young scientists

Profile Alzheimer’s Disease Neurological Disease Huang Lab

Article September 9, 2024

Hope for Alzheimer’s: A Conversation with Gladstone’s Lennart Mucke

Mucke, director of the Gladstone Institute of Neurological Disease, discusses what's next for Alzheimer’s research, the role of nonprofit research in developing new therapies, and why he's more hopeful than ever for a future where neurodegenerative diseases are fully treatable—and even preventable.

Alzheimer’s Disease Neurological Disease Mucke Lab Aging

Gladstone in the News September 6, 2024

USF Trustee Connects Biotechnology Master’s Students with Exclusive Career Exploration Opportunity

University of San Francisco—Students in the Master’s in Biotechnology program at the University of San Francisco visited Gladstone to learn about industry-altering scientific breakthroughs and met with Benoit Bruneany, director of the Gladstone Institute of Cardiovascular Disease, and Stephen Freedman, vice president of corporate liaison and ventures.

Gladstone Experts

Gladstone in the News September 6, 2024

Phage Therapy Could Leverage Retrons to Overcome Antibiotic Resistance

Genetic Engineering & Biotechnology News—Gladstone Investigator Seth Shipman and his team developed a new technology using retrons to engineer bacteria-fighting viruses known as phages, which could be used to kill antibiotic-resistant bacteria.

Gladstone Experts Shipman Lab

Article September 5, 2024

New Technology Could Lead to Alternative Treatments for Antibiotic-Resistant Bacteria

Scientists at Gladstone Institutes develop a streamlined and rapid way to engineer bacteria-fighting viruses known as phages

News Release Research (Publication) Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing

Article September 5, 2024

Gladstone Institutes Launches Capital Campaign to Accelerate a Biomedical Revolution

The $350 million Gladstone NOW campaign will raise funds to expand Gladstone’s footprint, hire hundreds of additional scientists, and seize emerging opportunities for high-impact biomedical research that can overcome disease.

Philanthropy Institutional News News Release

Article September 4, 2024

Gladstone’s Catherine Tcheandjieu Gueliatcha Named an ‘Emerging Leader’ by National Academy of Medicine

Tcheandjieu is one of 10 scholars nationwide selected as an emerging leader who's shaping the future of health and medicine.

Awards News Release Heart Failure Data Science and Biotechnology Tcheandjieu Lab AI Big Data

Gladstone in the News August 29, 2024

Blood Clotting Protein Discovery Upends Conventional COVID-19 Thinking, IDs Potential Therapy

Inside Precision Medicine—A new study by Gladstone Senior Investigators Katerina Akassoglou and Warner Greene shows that fibrin, a blood coagulation protein, drives the cascade of symptoms that are the hallmarks of infection by the SARS-CoV-2 virus.

Gladstone Experts COVID-19 Akassoglou Lab

Gladstone in the News August 28, 2024

Structure Search Suggests Roles for Thousands of Viral Proteins

Chemical & Engineering News—In a new study, scientists in Jennifer Doudna’s lab probe how viruses interfere with host signaling. Postdoctoral Fellow Jason Nomburg explains how they assembled a database of predicted structures of viral proteins, and used it to find the functions of previously mysterious proteins.

Gladstone Experts Infectious Disease Doudna Lab

Article August 28, 2024

Discovery of How Blood Clots Harm Brain and Body in COVID-19 Points to New Therapy

A new study in Nature overturns the prevailing theory that blood clotting is merely a consequence of inflammation in COVID-19.

News Release Research (Publication) COVID-19 Neurological Disease Infectious Disease Akassoglou Lab

Gladstone in the News August 27, 2024

San Francisco’s Role in the Mpox Fight

The Voice of San Francisco—Melanie Ott, director of the Gladstone Institute of Virology, answers questions about mpox at a time when many people are wondering about the virus’s ability to become another global pandemic, and also talks about how she and her team are contributing to the fight against it.

Gladstone Experts Infectious Disease Ott Lab

Article August 26, 2024

3D Shapes of Viral Proteins Point to Previously Unknown Roles

Scientists uncover an ancient immune-evading strategy shared by animal viruses and viruses that infect bacteria; findings may help in the development of new antiviral therapies

News Release Research (Publication) Data Science and Biotechnology Infectious Disease Doudna Lab CRISPR/Gene Editing

Article August 26, 2024

PUMAS Program Receives Five-Year Grant to Fuel Outreach, Diversify Science

The impactful summer internship program, created at Gladstone Institutes, immerses select undergraduates in cutting-edge science

Postdoctoral and Graduate Student Education and Research Development Affairs Student Outreach and Science Education Institutional News Diversity

Article August 19, 2024

Industry Partnership Forum Offers Insider Look at Scientific Breakthroughs from Gladstone

The annual event hosted by Gladstone Institutes showcases its most promising scientific discoveries for interested investors and potential industry partners

Corporate Liaison and Ventures Business Development Institutional News